Frank X. Leonard, Chief Executive Officer at NovoCure Ltd (NVCR), sold 34,273 shares at $17.93 ($615K) on 2026-06-04, disclosed to the SEC on 2026-06-05.
Open-market sale of $615k NVCR by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |
| NVCR | SELL | 2025-03-03 | $552K | — | Filing → |